During month 3 to year 1 of treatment, there was an overall trend toward decreasing levels of all the cytokines/chemokines tested in both groups.
← all excerpts
Slow reduction of IP-10 Levels predicts HBeAg seroconversion in chronic hepatitis B patients with 5 years of entecavir treatment.
2
—
—
The sentences
During the first 3 months of antiviral treatment, an increasing trend in levels of IL-6, PDGF-BB and RANTES was observed in both patient groups, while a trend toward increasing levels of IL-8 and IFN-γ was observed exclusively in patients with HBeAg seroconversion.